MedGenome and Genomics in India

In India, genomics is now the new normal. This was largely possible due to the increasing participation of various Indian startups. One such venture is MedGenome.

In India, genomics is now the new normal. This was largely possible due to the increasing participation of various Indian startups. One such venture that has claimed the title of having South Asia’s largest genomics database is MedGenome.

The venture was started by Sam Santhosh who surprisingly had no previous experience in this field. Santhosh was previously a part of the USA’s software industry. Around 2008, he noticed the rage of genome sequencing catching up. This pushed him to start Science of the Genome in Cochin in 2011. Two years later he felt the time was right to bring MedGenome into the picture.

MedGenome offered doctor-prescribed genetic diagnostic tests for patients. Tests for cancer, neurological disorders, eye diseases, prenatal disorders and metabolic diseases were all possible with MedGenome. They went a step ahead and launched KardioGen which can help detect the risk a person has of cardiac arrests. They also co-founded GenomeAsia 100K to promote research work and partnership in this field.

They raised $4 million in their Series A round by Papillon Capital. The next year they raised $20 million from Sequoia Capital India. Sequoia Capital again invested $20 million with Sofina. In 2018, HDFC ERGO invested $10 million. LeapFrog Investments raised $55 million in their Series D round in 2020. 

This year, the International Finance Corporation or IFC (member of the World Bank Group) invested ₹123 crores in MedGenome to make their COVID-19 diagnostics available to a wider population. IFC’s Global Health Platform has kept aside $4 billion to help deliver vaccines and medicines during the pandemic. MedGenome is the beneficiary of this project.

It is with the contribution of startups like MedGenome that the Indian genetics diagnostics market is growing at a CAGR of 42% in the next 5 years. Globally, the sector will go from $13 billion in 2019 to $28.5 billion in 2026. Making genomics mainstream not only global but also local.

Tags : #MedGenome #SamSanthosh #Genomics #IFC #WorldBankGroup #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...


Trending Now

How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024
Food Safety and Drug Administration (FDA), Uttarakhand, National Association of Street Vendors of India (NASVI) and Nestlé India expand Project ‘Serve Safe Food’ in Uttarakhand July 16, 2024
IIT Kharagpur and University of Leeds Sign MoU for Joint Supervision of PhD ProgramsJuly 16, 2024
Puja Curtains go up with KHUTI PUJA at Hazra Park DurgotsabJuly 16, 2024
Algorand and SEWA Join Forces to Launch Digital Health Passport Initiative for Women's EmpowermentJuly 15, 2024
The Debate Over Menstrual Leave: Balancing Needs and Workplace EqualityJuly 15, 2024
Young Indians Face Higher Lung Cancer Risk: Insights and ImplicationsJuly 15, 2024
Honoring a Healthcare Pioneer: Indian-origin Dr. George Matthew's Legacy in the UAEJuly 15, 2024
The Role of Platelets and Monocytes: New Research InsightsJuly 13, 2024
Groundbreaking Discovery in Cancer Research: Over 5,000 Genetic Variations IdentifiedJuly 13, 2024
June 2024: The Hottest Month on Record and What It Means for Our PlanetJuly 13, 2024
Cambodia Angkor Air teams up with Çelebi India for Cargo OperationsJuly 12, 2024
Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024